Pinned Tweet
We're hiring!
Stämm is a biotechnology company where engineering, chemistry, biology, and software development teams (among many others) work side by side.
We have the pace of a startup, the rigor of R&D, and an interdisciplinary, problem-solving-focused environment.
We are live at #CrossingOverLATAM in Buenos Aires!
CTO Juan Martin Cabaleiro and Head of BD Román Ortega Bianchi are on the floor discussing the future of biomanufacturing.
Stop by today to learn how laminar flow solves legacy scale-up bottlenecks. #Biotech
Next week, Latin America’s biotechnology frontier expands at the inaugural Crossing Over LATAM BioExpo! From October 21 to 23, we’ll be at the Centro de Convenciones Buenos Aires (CEC) showcasing the future of biomanufacturing.
Reach out to [email protected] or check the link in the first comment to book a meeting with the team. See you there!
Reach out to [email protected] or check the link in the first comment to book a meeting with the team. See you there!
#Biomanufacturing #CrossingOverLATAM #Biotech #BuenosAires
Latin America’s biotechnology frontier is expanding. From October 21 to 23, science, industry, startups, and investment will gather at the Centro de Convenciones de Buenos Aires (CEC) for the inaugural Crossing Over LATAM BioExpo.
Reach out to [email protected] or check the link below to book a meeting.
#Biomanufacturing #CrossingOverLATAM #Biotech #BuenosAires
We are here at Meeting on the Mesa! Innovation Fellow Subhadeep Das is on the ground at the Arizona Biltmore.
If you are a CGT developer struggling with the shear stress of turbulent stirred tanks or the manual limits of endless T-flasks, find him on the floor.
He is ready to break down how our 3D-printed continuous architecture unlocks a higher surface-to-volume ratio and preserves cell phenotype.
Send us a DM to meet up or follow the link below. #CellTherapy #MeetingOnTheMesa #GeneTherapy
This automated, closed system eliminates contamination risks, bypasses the shear stress of traditional tanks, and preserves phenotype across the scale-up journey.
Reach out to connect with him on the floor to discuss scaling your adherent cell lines.
October 5–7, 2026 | Arizona Biltmore in Phoenix, Arizona, USA
Drop a comment or send a DM to book a meeting.
#CellTherapy #MeetingOnTheMesa #GeneTherapy #Bioprocessing
At Meeting on the Mesa, he is breaking down how Cell & Gene Therapy developers can transition away from volume-intensive, manual processes. By shifting to Stämm’s 3D-printed continuous architecture, teams unlock a higher surface-to-volume ratio within a smaller lab footprint.
Stem cell differentiation demands extreme precision in the microenvironment. This breaks down if you force sensitive primary cells into turbulent stirred tanks, but is impossible to scale when manually carrying it out with endless T-flasks.
Translating deep novel tech into decentralized biomanufacturing requires understanding both the molecular level and the global scale. Our Chief Strategy Officer, Faith Wallace-Gadsden, has spent her career building global public health ventures.
At BioSpain, she will be discussing how our High-Throughput Bioprocesor gives R&D teams ultra-low shear stress and continuous perfusion for biologics production with adherent or suspension cell cultures. Contact her or find her on the floor.